• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

法国转诊网络的地理可达性。IGéAS 研究计划的中期结果。

Geographical Accessibility of the Referral Networks in France. Intermediate Results from the IGéAS Research Program.

机构信息

Equipe Evaluation Médicale et Sarcomes, Centre Léon Bérard, Université Claude Bernard Lyon 1, HESPER EA 7425, 69008 Lyon, France.

Institut Bergonié, RRePS Network, 33000 Bordeaux, France.

出版信息

Int J Environ Res Public Health. 2018 Oct 10;15(10):2204. doi: 10.3390/ijerph15102204.

DOI:10.3390/ijerph15102204
PMID:30308955
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6210416/
Abstract

Rare cancer patients face lower survival and experience delays in diagnosis and therapeutic mismanagement. Considering the specificities of rare cancers, referral networks have been implemented in France to improve the management and survival of patients. The IGéAS research program aims to assess the networks' ability to reduce inequalities. Data analysis of the IGéAS cohort ( = 20,590, sarcoma diagnosed between 2011 and 2014) by gathering medical data and geographical index will identify risk factors associated with the belated access to expertise or with no access to expertise. Intermediate results show that referral networks give sarcoma patients access to sarcoma expertise despite the remoteness of some of them. Regional expert centers mostly receive requests from within their area while national referral centers receive requests from the whole country. Delays in the access to expertise may be reduced by making outside practitioners more sensitive to the issues of rare cancers. The perception and involvement of outside practitioners in this device will be assessed using a qualitative survey. All the results are discussed and will contribute to design guidelines to improve early access to expertise and reduce inequalities. Results of the IGéAS research program may contribute to the assessment of referral sarcoma networks and provide some useful lessons to improve cancer care management.

摘要

罕见癌症患者的生存率较低,且在诊断和治疗管理方面存在延误。考虑到罕见癌症的特殊性,法国已经建立了转诊网络,以改善患者的管理和生存率。IGéAS 研究计划旨在评估网络减少不平等的能力。通过收集医疗数据和地理指数,对 IGéAS 队列(= 20590 例,2011 年至 2014 年间诊断为肉瘤)进行数据分析,将确定与延迟获得专业知识或无法获得专业知识相关的风险因素。中期结果表明,转诊网络使肉瘤患者能够获得肉瘤专业知识,尽管其中一些患者的地理位置偏远。区域专家中心主要接收本地区的请求,而国家转诊中心则接收来自全国各地的请求。通过提高外部从业者对罕见癌症问题的敏感性,可以减少获得专业知识的延迟。将使用定性调查评估外部从业者对该设备的认知和参与度。所有结果都将进行讨论,并有助于制定指导方针,以改善早期获得专业知识和减少不平等。IGéAS 研究计划的结果可能有助于评估转诊肉瘤网络,并为改善癌症护理管理提供一些有益的经验教训。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2ae/6210416/c294ec8d9600/ijerph-15-02204-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2ae/6210416/559d9d2f2652/ijerph-15-02204-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2ae/6210416/59ce0d985c93/ijerph-15-02204-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2ae/6210416/1c553d3750f1/ijerph-15-02204-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2ae/6210416/c294ec8d9600/ijerph-15-02204-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2ae/6210416/559d9d2f2652/ijerph-15-02204-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2ae/6210416/59ce0d985c93/ijerph-15-02204-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2ae/6210416/1c553d3750f1/ijerph-15-02204-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2ae/6210416/c294ec8d9600/ijerph-15-02204-g004.jpg

相似文献

1
Geographical Accessibility of the Referral Networks in France. Intermediate Results from the IGéAS Research Program.法国转诊网络的地理可达性。IGéAS 研究计划的中期结果。
Int J Environ Res Public Health. 2018 Oct 10;15(10):2204. doi: 10.3390/ijerph15102204.
2
Determinants of the access to remote specialised services provided by national sarcoma reference centres.获取国家肉瘤参考中心提供的远程专科服务的决定因素。
BMC Cancer. 2021 May 29;21(1):631. doi: 10.1186/s12885-021-08393-4.
3
No Geographical Inequalities in Survival for Sarcoma Patients in France: A Reference Networks' Outcome?法国肉瘤患者生存不存在地理不平等:参考网络的结果?
Cancers (Basel). 2022 May 25;14(11):2620. doi: 10.3390/cancers14112620.
4
Imaging investigations before referral to a sarcoma center delay the final diagnosis of musculoskeletal sarcoma.在转诊至肉瘤中心之前进行影像学检查会延迟肌肉骨骼肉瘤的最终诊断。
Acta Orthop. 2017 Apr;88(2):211-216. doi: 10.1080/17453674.2016.1278113. Epub 2017 Jan 12.
5
Impact of dermatology eConsults on access to care and skin cancer screening in underserved populations: A model for teledermatology services in community health centers.皮肤病电子咨询对服务不足人群获得医疗服务和皮肤癌筛查的影响:社区卫生中心远程皮肤病学服务的模型。
J Am Acad Dermatol. 2018 Feb;78(2):293-302. doi: 10.1016/j.jaad.2017.09.017. Epub 2017 Oct 20.
6
Simple guidelines for efficient referral of soft-tissue sarcomas: a population-based evaluation of adherence to guidelines and referral patterns.软组织肉瘤有效转诊的简易指南:基于人群的指南遵循情况和转诊模式评估。
J Bone Joint Surg Am. 2012 Jul 18;94(14):1291-6. doi: 10.2106/JBJS.K.01271.
7
Epidemiology of rare cancers and inequalities in oncologic outcomes.罕见癌症的流行病学和肿瘤学结局的不平等。
Eur J Surg Oncol. 2019 Jan;45(1):3-11. doi: 10.1016/j.ejso.2017.08.018. Epub 2017 Sep 19.
8
Dental screening and referral of young children by pediatric primary care providers.儿科初级保健提供者对幼儿进行牙科筛查和转诊。
Pediatrics. 2004 Nov;114(5):e642-52. doi: 10.1542/peds.2004-1269.
9
Shortening the Time Interval for the Referral of Patients With Soft Tissue Sarcoma to Expert Centers Using Mobile Health: Retrospective Study.使用移动医疗缩短软组织肉瘤患者转至专家中心的时间间隔:回顾性研究。
JMIR Mhealth Uhealth. 2022 Nov 9;10(11):e40718. doi: 10.2196/40718.
10
An Age Stratified Analysis of the Access to Care Continuum Across Three Tumor Groups: Are There Delays for AYA?按年龄分层分析三个肿瘤群组的就诊连续性:青少年和年轻成人是否存在就诊延误?
J Adolesc Young Adult Oncol. 2019 Aug;8(4):402-409. doi: 10.1089/jayao.2018.0126. Epub 2019 Mar 26.

引用本文的文献

1
Is rare cancer care organized at national health system level? Multiple case study in six EU countries.是否在国家卫生系统层面组织罕见癌症的治疗?六个欧盟国家的多案例研究。
Eur J Public Health. 2022 Nov 29;32(6):852-857. doi: 10.1093/eurpub/ckac166.
2
Shortening the Time Interval for the Referral of Patients With Soft Tissue Sarcoma to Expert Centers Using Mobile Health: Retrospective Study.使用移动医疗缩短软组织肉瘤患者转至专家中心的时间间隔:回顾性研究。
JMIR Mhealth Uhealth. 2022 Nov 9;10(11):e40718. doi: 10.2196/40718.
3
No Geographical Inequalities in Survival for Sarcoma Patients in France: A Reference Networks' Outcome?

本文引用的文献

1
Improved survival using specialized multidisciplinary board in sarcoma patients.在肉瘤患者中使用专门的多学科委员会可提高生存率。
Ann Oncol. 2017 Nov 1;28(11):2852-2859. doi: 10.1093/annonc/mdx484.
2
Epidemiology of rare cancers and inequalities in oncologic outcomes.罕见癌症的流行病学和肿瘤学结局的不平等。
Eur J Surg Oncol. 2019 Jan;45(1):3-11. doi: 10.1016/j.ejso.2017.08.018. Epub 2017 Sep 19.
3
Treatment challenges in and outside a network setting: Soft tissue sarcomas.治疗挑战在网络环境内外:软组织肉瘤。
法国肉瘤患者生存不存在地理不平等:参考网络的结果?
Cancers (Basel). 2022 May 25;14(11):2620. doi: 10.3390/cancers14112620.
4
Disparities in Healthcare Services and Spatial Assessments of Mobile Health Clinics in the Border Regions of Thailand.中泰边境地区医疗服务差距与流动医疗诊所空间评估。
Int J Environ Res Public Health. 2021 Oct 14;18(20):10782. doi: 10.3390/ijerph182010782.
5
European Reference Network for rare adult solid cancers, statement and integration to health care systems of member states: a position paper of the ERN EURACAN.欧洲罕见成人实体癌参考网络:声明及与成员国医疗保健系统的整合——ERN EURACAN立场文件
ESMO Open. 2021 Aug;6(4):100174. doi: 10.1016/j.esmoop.2021.100174. Epub 2021 Jun 15.
6
Determinants of the access to remote specialised services provided by national sarcoma reference centres.获取国家肉瘤参考中心提供的远程专科服务的决定因素。
BMC Cancer. 2021 May 29;21(1):631. doi: 10.1186/s12885-021-08393-4.
7
Diagnosed with a Rare Cancer: Experiences of Adult Sarcoma Survivors with the Healthcare System-Results from the SURVSARC Study.被诊断患有罕见癌症:成人肉瘤幸存者在医疗系统中的经历——SURVSARC研究结果
Cancers (Basel). 2021 Feb 8;13(4):679. doi: 10.3390/cancers13040679.
8
Benefits and Limitations of a Multidisciplinary Approach in Cancer Patient Management.癌症患者管理中多学科方法的益处与局限性
Cancer Manag Res. 2020 Sep 30;12:9363-9374. doi: 10.2147/CMAR.S220976. eCollection 2020.
Eur J Surg Oncol. 2019 Jan;45(1):31-39. doi: 10.1016/j.ejso.2017.09.015. Epub 2017 Sep 19.
4
Survival impact of centralization and clinical guidelines for soft tissue sarcoma (A prospective and exhaustive population-based cohort).软组织肉瘤集中化治疗及临床指南的生存影响(一项基于人群的前瞻性详尽队列研究)
PLoS One. 2017 Feb 3;12(2):e0158406. doi: 10.1371/journal.pone.0158406. eCollection 2017.
5
Management of desmoid tumours: A nationwide survey of labelled reference centre networks in France.硬纤维瘤的管理:法国标记参考中心网络的全国性调查。
Eur J Cancer. 2016 May;58:90-6. doi: 10.1016/j.ejca.2016.02.008. Epub 2016 Mar 11.
6
The value of research collaborations and consortia in rare cancers.研究合作和联盟在罕见癌症中的价值。
Lancet Oncol. 2016 Feb;17(2):e62-e69. doi: 10.1016/S1470-2045(15)00388-5.
7
Role of expert centres in the management of sarcomas--a UK perspective.肉瘤治疗中专家中心的作用——英国的观点。
Eur J Cancer. 2014 Jul;50(11):1951-6. doi: 10.1016/j.ejca.2014.04.006. Epub 2014 May 21.
8
Construction of an adaptable European transnational ecological deprivation index: the French version.构建一个适应性强的欧洲跨国生态剥夺指数:法国版本。
J Epidemiol Community Health. 2012 Nov;66(11):982-9. doi: 10.1136/jech-2011-200311. Epub 2012 Apr 27.
9
Technical considerations in surgery for retroperitoneal sarcomas: position paper from E-Surge, a master class in sarcoma surgery, and EORTC-STBSG.腹膜后肉瘤手术的技术考虑因素:来自 E-Surge(肉瘤手术大师班)和 EORTC-STBSG 的立场文件。
Ann Surg Oncol. 2012 Sep;19(9):2981-91. doi: 10.1245/s10434-012-2342-2. Epub 2012 Apr 3.
10
Sarcoma: concordance between initial diagnosis and centralized expert review in a population-based study within three European regions.肉瘤:在三个欧洲地区的基于人群的研究中,初始诊断与集中专家审查之间的一致性。
Ann Oncol. 2012 Sep;23(9):2442-2449. doi: 10.1093/annonc/mdr610. Epub 2012 Feb 13.